Filing Details
- Accession Number:
- 0001465826-13-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-19 21:08:30
- Reporting Period:
- 2013-11-14
- Filing Date:
- 2013-11-19
- Accepted Time:
- 2013-11-19 21:08:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1465825 | G Ashok Nigalaye | C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413 | Chief Scientific Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-14 | 465,090 | $0.12 | 24,200,069 | No | 4 | S | Indirect | By Epic Investments, LLC |
| Common Stock | Disposition | 2013-11-15 | 318,050 | $0.12 | 24,095,113 | No | 4 | S | Indirect | By Epic Investments, LLC |
| Common Stock | Disposition | 2013-11-18 | 1,170,000 | $0.12 | 21,553,648 | No | 4 | S | Indirect | By Epic Investments, LLC |
| Common Stock | Disposition | 2013-11-19 | 21,000 | $0.12 | 21,547,348 | No | 4 | S | Indirect | By Epic Investments, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Epic Investments, LLC |
| No | 4 | S | Indirect | By Epic Investments, LLC |
| No | 4 | S | Indirect | By Epic Investments, LLC |
| No | 4 | S | Indirect | By Epic Investments, LLC |
Footnotes
- Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Investments, LLC ("EI") and Epic Pharma, LLC ("EP"), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
Billionaire Hedge Funds
